BioImaging-GR is an initiative aiming to establish a state-of-the-art Biological Imaging infrastructure in Greece, within the framework of Euro-BioImaging, the related pan-European ESFRI Research Infrastructure (http://www.eurobioimaging.eu/). BioImaging approaches are becoming widely used and are greatly appreciated as cutting-edge tools for dissecting complex biological phenomena, for understanding cell structure and dynamics, and for extracting biological information of clinical relevance. Recent advances in imaging technologies and the development of several innovative microscopy modes have opened new vistas in the field of Biological Imaging that is rapidly gaining critical importance in the area of Life Sciences. BioImaging-GR aims to create a strongly interlinked and geographically distributed infrastructure for general-access, high-end biological imaging providing a range of imaging methods to scientists, interested stakeholders, SMEs and enterprises in Greece and neighboring countries. Moreover, BioImaging-GR will seek to acquire and provide access to “beyond state-of-the-art” imaging technologies, which are not easily accessible to the broader imaging community. In addition to the acquisition and upgrade of facilities, BioImaging-GR will introduce new expertise, relevant to biomedical imaging through recruitment and training of resident personnel. Through BioImaging-GR, the national investment in imaging infrastructure will be used in the most cost-effective and efficient way by applying the highest quality standards in management, access and service of imaging facilities. Modernizing BioImaging infrastructure and acquiring or generating the necessary expertise will allow Greece to maintain a competitive position in the field of Biomedical research, and provide cutting-edge facilities to the broader research community in south-east Europe.

ACTPHAST 4.0 supports and accelerates the innovation capacity of European companies by providing them with direct access to the expertise and state-of-the-art facilities of Europe's leading photonics research centres (the ACTPHAST 4.0 Partners), enabling companies to exploit the tremendous commercial potential of applied photonics. There are 24 research institutes who together make up the ACTPHAST 4.0 Partners.

Together the ACTPHAST 4.0 Partners provide a full spectrum of photonics technology platforms ranging from fibre optics and micro optics, to highly integrated photonic platforms (7 technology platforms in all), with capabilities extending from design through to full system prototyping.

ACTPHAST 4.0 operates as an open call to all European companies (big and small, but particularly targeted at SMEs) so they can avail of timely, cost-effective, and low risk photonics innovation support, and that the extensive range of capabilities within the consortium can impact across a wide range of industrial sectors and application domains, from communications to consumer-related products, and life sciences to industrial manufacturing.

The access to top-level experts and leading photonics technology platforms provided by the ACTPHAST 4.0 consortium is realized through focused innovation projects executed in relatively short timeframes (typically 6-9 months) with a critical mass of suitably qualified companies with high potential product concepts.  The technical innovation support is supplemented by expert business and financial coaching supports to help ensure that the innovation activities are also commercially focused and primed for market success. ACTPHAST 4.0 is closely aligned with the Photonics Pilot Lines and Mass Manufacturing in Europe to seamlessly progress successful prototypes developed through the ACTPHAST 4.0 incubator all the way to large-scale production and market-ready products. In addition, ACTPHAST 4.0 includes Europe Unlimited as a 25th partner in the consortium who run the highly successful TechTour program around Europe each year to match venture capital with high potential start-ups and scale-ups in key technology areas. Together with this partner and in closely collaboration with Photonics21 and the Photonics PPP, ACTPHAST 4.0 will deliver the European Photonics Venture Forum (EPVF) once a year at key locations around Europe to help boost the level of new financial investment sources for photonics innovation by European companies.

As a result of its innovation support activities, ACTPHAST 4.0 is expected to deliver a substantial increase in the revenues and employment numbers of the supported companies by enabling faster time-to-market of new product opportunities and addressing emerging markets where photonics is a key enabling technology. Furthermore, through its extensive outreach activities, ACTPHAST 4.0 will ensure there is an increased level of awareness and understanding across European industries of the technical and commercial potential of photonics, especially amongst first users and "non-photonics" end user industries.

ACTPHAST 4.0 is particularly suited to the needs of small to medium-sized enterprises (SMEs) who do not have the financial resources to invest in in-house R&D expertise and state-of-the-art technologies, nor to undertake risky innovation projects.  ACTPHAST 4.0 support is heavily subsidized for projects undertaken with SMEs (100% subsidy for the first 30K€ of costs for an innovation project and 75% subsidy for all project costs over 30K€ including follow-on projects with the same company. For large-scale companies, the subsidy is 50% on all project costs).

ACTPHAST 4.0 is designed to provide open access to photonics innovation support for all European companies who meet the eligibility criteria, and we have strict governance structures and systems in place around the key persons responsible for running the program to ensure that ACTPHAST 4.0 remains true to its mission and mandate, and that all decisions are open, transparent and properly accounted for.

ACTPHAST 4.0 supports and accelerates the innovation capacity of European companies by providing them with direct access to the expertise and state-of-the-art facilities of Europe's leading photonics research centres (the ACTPHAST 4.0 Partners), enabling companies to exploit the tremendous commercial potential of applied photonics. There are 24 research institutes who together make up the ACTPHAST 4.0 Partners.

Together the ACTPHAST 4.0 Partners provide a full spectrum of photonics technology platforms ranging from fibre optics and micro optics, to highly integrated photonic platforms (7 technology platforms in all), with capabilities extending from design through to full system prototyping.

ACTPHAST 4.0 operates as an open call to all European companies (big and small, but particularly targeted at SMEs) so they can avail of timely, cost-effective, and low risk photonics innovation support, and that the extensive range of capabilities within the consortium can impact across a wide range of industrial sectors and application domains, from communications to consumer-related products, and life sciences to industrial manufacturing.

The access to top-level experts and leading photonics technology platforms provided by the ACTPHAST 4.0 consortium is realized through focused innovation projects executed in relatively short timeframes (typically 6-9 months) with a critical mass of suitably qualified companies with high potential product concepts.  The technical innovation support is supplemented by expert business and financial coaching supports to help ensure that the innovation activities are also commercially focused and primed for market success. ACTPHAST 4.0 is closely aligned with the Photonics Pilot Lines and Mass Manufacturing in Europe to seamlessly progress successful prototypes developed through the ACTPHAST 4.0 incubator all the way to large-scale production and market-ready products. In addition, ACTPHAST 4.0 includes Europe Unlimited as a 25th partner in the consortium who run the highly successful TechTour program around Europe each year to match venture capital with high potential start-ups and scale-ups in key technology areas. Together with this partner and in closely collaboration with Photonics21 and the Photonics PPP, ACTPHAST 4.0 will deliver the European Photonics Venture Forum (EPVF) once a year at key locations around Europe to help boost the level of new financial investment sources for photonics innovation by European companies.

As a result of its innovation support activities, ACTPHAST 4.0 is expected to deliver a substantial increase in the revenues and employment numbers of the supported companies by enabling faster time-to-market of new product opportunities and addressing emerging markets where photonics is a key enabling technology. Furthermore, through its extensive outreach activities, ACTPHAST 4.0 will ensure there is an increased level of awareness and understanding across European industries of the technical and commercial potential of photonics, especially amongst first users and "non-photonics" end user industries.

ACTPHAST 4.0 is particularly suited to the needs of small to medium-sized enterprises (SMEs) who do not have the financial resources to invest in in-house R&D expertise and state-of-the-art technologies, nor to undertake risky innovation projects.  ACTPHAST 4.0 support is heavily subsidized for projects undertaken with SMEs (100% subsidy for the first 30K€ of costs for an innovation project and 75% subsidy for all project costs over 30K€ including follow-on projects with the same company. For large-scale companies, the subsidy is 50% on all project costs).

ACTPHAST 4.0 is designed to provide open access to photonics innovation support for all European companies who meet the eligibility criteria, and we havestrict governance structures and systems in place around the key persons responsible for running the program to ensure that ACTPHAST 4.0 remains true to its mission and mandate, and that all decisions are open, transparent and properly accounted for.

EUSMI aims to enhance the European competitiveness in soft-matter research and innovation through the integration and the extension of the scope of existing specialized infrastructures. A full suite of coherent key infrastructures and the corresponding expertise from 15 top-level institutions are combined within EUSMI, accessible to a broad community of researchers operating at different levels of the value chain, including SMEs and applied research.

The infrastructures cover the full chain of functional soft-matter material research, ranging from advanced material characterization by a full suite of specialized experimental installations, including large-scale facilities, chemical synthesis of a full set of soft-matter materials, up-scaling of laboratory synthesis, to modeling by high-performance supercomputing. The existing infrastructure will be continuously improved and advanced by Joint Research Activity (JRA).

An ambitious networking program ensures efficient dissemination and communication, supporting continued education of established researchers and training of emerging scientists. EUSMI drives academic research and innovation in soft nanotechnology. It provides a multidisciplinary set of essential research capabilities and expertise to guide users. It also develops the next generation of techniques and instruments to synthesize, characterize, and numerically simulate novel soft matter materials. It contributes to the creation of a broad knowledge basis.

EUSMI provides the community of European soft-matter researchers with an open-access infrastructure as a platform to support and extend their research, covering characterization, synthesis, and modeling.